Healthcare specialist agency Kyne has established a London office. The firm appointed Joanne Wunder, a veteran of inVentiv Health, as managing director and head of Europe, reporting to founder and CEO David Kyne. Wunder will lead Kyne’s Dublin and London offices. Prior to joining Kyne, Wunder was European managing director for PR at inVentiv Health and a business unit head at Ogilvy Healthworld.

Nimbus Therapeutics has appointed Peter Tummino as chief scientific officer. Most recently, he served as VP and global head of lead discovery in discovery sciences at Janssen. Prior, Tummino worked at GlaxoSmithKline.

Cerevel Therapeutics, a biopharma company that develops treatments for central nervous system disorders, named Raymond Sanchez as chief medical officer. He will oversee clinical development of the company’s pipeline, including late-stage programs that could be potential treatments for symptoms of Parkinson’s disease and epilepsy, respectively.

Joerns Healthcare has named Kevin Conway as its chief commercial officer. Previously, Conway started consultancy PBMK Engineering and was VP of global business development at Stryker Medical.

Upwell Health has appointed Patrick Gross as CFO. He previously served as the agency’s chief administrative officer, a role in which he worked on new product strategy and a pilot consultative sales program. The firm also recently hired Tim Moran as VP of editorial and digital content and Bridget Quinlan as chief strategy officer.

Team Novo Nordisk has promoted Fitzalan Crowe to VP of marketing and sponsorship. Previously, she led communications and media relations for the bicycling team for the past five years. Crowe started with Team Novo Nordisk in late 2013 and was most recently its senior director of public relations.

Health Unlimited brought on Jason Galla-Barth as practice leader for brand promotion in the U.K., and Dan Burgess as director of digital engagement in the U.S. Galla-Barth was most recently U.K. head of digital for Sudler; based in London, he will report to CEO Tim Bird. Burgess was previously director of Boehringer Ingelheim’s digital marketing center of excellence; he will be based in New York and report to Susan Duffy, chief strategy officer.

Client-side people moves courtesy of MM&M sister brand The PMD